pimagedine has been researched along with Insulinoma in 3 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
Insulinoma: A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cetkovic-Cvrlje, M | 1 |
Eizirik, DL | 1 |
Corbett, JA | 1 |
McDaniel, ML | 1 |
Tajiri, Y | 1 |
Grill, V | 1 |
3 other studies available for pimagedine and Insulinoma
Article | Year |
---|---|
TNF-alpha and IFN-gamma potentiate the deleterious effects of IL-1 beta on mouse pancreatic islets mainly via generation of nitric oxide.
Topics: Animals; Drug Synergism; Evaluation Studies as Topic; Guanidines; Insulinoma; Interferon-gamma; Inte | 1994 |
Selective inhibition of inducible nitric oxide synthase by aminoguanidine.
Topics: Animals; Arginine; Brain; Cell Line; Endothelium, Vascular; Enzyme Induction; Enzyme Inhibitors; Gua | 1996 |
Aminoguanidine exerts a beta-cell function-preserving effect in high glucose-cultured beta-cells (INS-1).
Topics: Animals; Cell Line; Gene Expression Regulation; Glucose; Glycation End Products, Advanced; Guanidine | 2000 |